Northside Capital Management’s Amgen AMGN Stock Holding History

Northside Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,871	Closed	-$730K	–	93
2020 Q3	$730K	Hold	2,871	–	–	0.24%	43
2020 Q2	$677K	Hold	2,871	–	–	0.23%	52
2020 Q1	$582K	Hold	2,871	–	–	0.28%	40
2019 Q4	$692K	Hold	2,871	–	–	0.24%	42
2019 Q3	$556K	Sell	2,871 -75	-3%	-$14.4K	0.2%	48
2019 Q2	$543K	Hold	2,946	–	–	0.21%	40
2019 Q1	$560K	Hold	2,946	–	–	0.22%	42
2018 Q4	$573K	Buy	2,946 +75	+3%	+$14.6K	0.25%	38
2018 Q3	$595K	Hold	2,871	–	–	0.21%	37
2018 Q2	$530K	Hold	2,871	–	–	0.19%	40
2018 Q1	$489K	Hold	2,871	–	–	0.16%	50
2017 Q4	$499K	Hold	2,871	–	–	0.14%	49
2017 Q3	$535K	Hold	2,871	–	–	0.22%	38
2017 Q2	$494K	Hold	2,871	–	–	0.21%	37
2017 Q1	$471K	Hold	2,871	–	–	0.13%	91
2016 Q4	$420K	Hold	2,871	–	–	0.15%	46
2016 Q3	$479K	Hold	2,871	–	–	0.18%	39
2016 Q2	$437K	Hold	2,871	–	–	0.21%	41
2016 Q1	$430K	Buy	+2,871	New	+$427K	0.27%	40

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Northside Capital Management's AMGN Position: Q4 2020 in Review

Northside Capital Management sold out of Amgen (AMGN) in Q4 2020, closing a stake of 2,871 shares — an estimated $730K sold.

Northside Capital Management first reported a position in AMGN in Q1 2016 and held it in 19 quarters. The position peaked at $730K in Q3 2020. 2,220 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Northside Capital Management reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
Northside Capital Management sold 2,871 Amgen shares in Q4 2020, an estimated $730K.
Northside Capital Management first reported a position in Amgen in Q1 2016 and held it in 19 quarters.
Northside Capital Management's Amgen position peaked at $730K in Q3 2020.
2,220 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Northside Capital Management's 13F filing for Q4 2020, filed 22 Jan 2021.